Doctors prescribe glimepiride to help control blood sugar levels in people with type 2 diabetes.
Glimepiride increases the risk of dangerously low blood sugar levels. People who take this medication must, therefore, check their blood sugar levels regularly.
Glimepiride may also cause other side effects, especially when taken with certain other medications. This article outlines the potential side effects and risks of taking glimepiride. We also provide information on glimepiride dosages and its interactions with other drugs.
Glimepiride is an oral medication that doctors prescribe to treat type 2 diabetes. Glimepiride belongs to a class of drugs called sulfonylureas.
Sulfonylureas work by increasing the amount of insulin released from the pancreas. Insulin lowers blood sugar levels by increasing the amount of glucose the body can store in its cells.
Sulfonylureas are not suitable for people with type 1 diabetes. People with type 1 diabetes have a dysfunctional pancreas that cannot produce enough insulin. Drugs that stimulate the release of insulin would not be effective.
Doctors group sulfonylureas into two different classes: first and second generation sulfonylureas.
The following table lists the available sulfonylureas in the United States according to their class.
|First generation||Second generation|
|chlorpropamide (Diabinese)||glipizide (Glucotrol)|
|tolazamide (Tolinase)||glyburide (Glynase)|
|tolbutamide (Orinase)||glimepiride (Amaryl)|
The difference between first and second generation sulfonylureas is their potency, with the second generation being more potent. However, there is no evidence to suggest that one generation is more effective than the other.
Doctors sometimes classify glimepiride as a third generation sulfonylurea.
People may receive glimepiride alongside other antidiabetic medications. These drug combinations are usually necessary for people who are unable to reach their target blood sugar levels.
Doctors use a test called the A1C test to record a person’s average blood sugar levels. It does this by measuring the amount of glucose attached to hemoglobin in a person’s red blood cells.
People with diabetes have A1C values higher than 6.5%. The first-line treatment for elevated levels is metformin (Glucophage). However, a doctor may prescribe glimepiride for people who are unable to take metformin.
If a person’s A1C values do not fall below 7.0% after 3 months of taking metformin, the doctor may choose to add glimepiride. Alternatively, they may add another type of antidiabetic medication.
If a person’s initial A1C reading is over 9.0%, the doctor may prescribe both metformin and glimepiride at the start of treatment. Alternatively, they may prescribe some other combination of antidiabetic medications.
Doctors will order regular blood tests to check a person’s blood sugar levels. People may receive these tests up to four times per year.
Sulfonylureas, including glimepiride, can decrease A1C values by about 1.5%.
Glimepiride is only available in oral form. A doctor may prescribe it in one of the following dosages.
1 milligram (mg), 2 mg, 3 mg, 4 mg, 6 mg, 8 mg
Doctors will prescribe glimepiride once daily. People should take it with breakfast or the first meal of the day.
People will usually start on a low dose of glimepiride, which is about 1 mg or 2 mg once per day. A doctor will then increase the dose every 1 or 2 weeks, depending on the person’s blood sugar control.
People who are at risk of experiencing low blood sugar levels will start with 1 mg of glimepiride per day. If necessary, the doctor will increase this dose gradually. These gradual increases should reduce the risk of low blood sugar levels.
The maximum daily dose of glimepiride is 8 mg once daily.
Some people only experience symptoms of hypoglycemia when their blood sugar levels drop to 55 mg/dL.
A person who has hypoglycemia may experience the following symptoms:
- nervousness and anxiety
- rapid heartbeat
- paleness or loss of color in the skin
- blurred vision
- tingling or numbness of the lips, tongue, or cheeks
The treatment for hypoglycemia is glucose. The American Diabetes Association recommend that people follow the 15-15 rule when taking glucose to treat hypoglycemia.
The 15-15 rule recommends that people consume 15 grams (g) of carbohydrate and check their blood sugar levels 15 minutes later. If the blood sugar levels are still below 70 mg/dL, the person should have another serving. People should repeat this process until their blood sugar reaches at least 70 mg/dL.
People can get 15 g of sugar from the following sources:
- glucose tablets
- gel tubes
- 4 ounces or 1/2 cup of juice or regular (not diet) soda
- 1 tablespoon of honey, sugar, or corn syrup
- hard candies, jellybeans, or gumdrops
Other potential side effects of glimepiride include:
- accidental injury, possibly as a result of low hypoglycemia
- flu-like symptoms
- weight gain
Apart from the risk of hypoglycemia, there are several other warnings to consider when taking glimepiride.
Cardiovascular disease and death
The UGDP found that people who took the sulfonylurea “tolbutamide” were 2.5 times more likely to die from CD compared to people who did not take the drug. The people who did not take tolbutamide received diabetes treatment in the form of dietary changes.
Although only one sulfonylurea was included in the study, it is possible that other types of sulfonylurea may present similar risks. Doctors must therefore weigh the benefits of these drugs against their potential risks. They may decide to try alternative treatments before prescribing glimepiride.
Glucose-6-phosphate dehydrogenase deficiency
People with a specific enzyme deficiency called glucose-6-phosphate dehydrogenase (G6PD) deficiency must use caution when taking sulfonylureas. Combining these drugs may cause hemolytic anemia.
Effects on pregnancy and lactation
Researchers have not identified any major birth defects or miscarriages in women taking glimepiride during pregnancy. However, some doctors have reported an increased risk of hypoglycemia in newborns whose mothers took glimepiride during pregnancy.
Doctors recommend stopping glimepiride 2 weeks before the expected delivery date to prevent any effects on the baby.
Researchers are unsure of how much glimepiride is released into breastmilk. If a breastfeeding woman must continue taking glimepiride, the pediatrician should routinely monitor the baby’s blood sugar levels.
Complications in older adults
Glimepiride is generally safe for use in older adults. However, with advanced age, the kidneys may be less effective at removing glimepiride from the system. This can lead to increased levels of glimepiride in the blood, which may result in hypoglycemia.
Doctors will routinely monitor kidney function in older people who are taking glimepiride.
If a person has had a severe allergic reaction to sulfonamides in the past, it may be necessary for them to avoid taking these drugs in future.
In some cases, a doctor may go ahead and prescribe a sulfonylurea to a person with a sulfa allergy. However, the doctor will monitor the person closely to check for early signs of a repeat allergic reaction.
As well as sulfa allergy, some people may experience other general hypersensitivities to the drug.
Medications that affect glucose control may interact with glimepiride. Insulin and other antidiabetic medications work with glimepiride to produce a combined hypoglycemic effect. Together, these drugs may lower blood sugar to a level that results in hypoglycemia.
While some medications may increase the glucose-lowering effect of glimepiride, some drugs can decrease its effect. The drugs in the following list can decrease the efficacy of sulfonylureas:
- atypical antipsychotics (e.g. olanzapine and clozapine)
- thiazides and other diuretics
A person who requires the above medications alongside glimepiride will need to monitor their blood sugar levels more frequently.
If the person stops taking one of the above medications, the effect of glimepiride may increase. In such cases, people should monitor their blood sugar levels to ensure they do not drop too low.
Both sulfonylureas and meglitinides stimulate the release of insulin from the pancreas, but each act on different pathways.
Since sulfonylureas and meglitinides have the same action, people should not take both drugs at the same time. Doing so could lead to hypoglycemia.
People who require a combination of antidiabetic medications will need to choose drugs from different classes.
Some other classes of antidiabetic medications include:
- alpha-glucosidase inhibitors
- dipeptidyl peptidase 4 (DPP- 4) inhibitors
- sodium-glucose cotransporter 2 (SGLT-2) inhibitors
Some of the above drugs offer additional benefits, such as aiding weight loss and preventing heart disease.
Sulfonylureas are a low cost antidiabetic drug. The following table lists the average retail prices of 30 tablets of
Second generation generic sulfonylureas.
|Not approved in the United Stated||1 mg, $14.97|
2 mg, $18.32
4 mg, $29.95
|5 mg, $11.17|
10 mg, $12.85
|1.25 mg, $12.41|
2.5 mg, $14.27
5 mg, $16.82
Glimepiride is an affordable and effective antidiabetic medication for people with type 2 diabetes. However, this drug may not be suitable for everyone. Doctors will therefore obtain a full medical history before prescribing glimepiride.
Glimepiride can increase the risk of low blood sugar levels. As such, people should regularly monitor their blood sugar levels to check that they are within a healthy range. People should follow the 15-15 rule when treating hypoglycemic episodes.
Doctors will prescribe alternative antidiabetic medications for people who are unable to take glimepiride or other sulfonylureas.